CNSI Cambridge Neuroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John B. Anderson who wrote (11)	8/1/1996 11:29:00 AM
From: John B. Anderson	of 675

I just wanted to add the results of talking to analyst Ed Hurwitz today. He was quite familiar with Citicoline, and claimed it works later in the "cascade" of neurological events, and was not really the drug of first choice in situations where Cerestat would clearly be indicated. He also talked skeptically about how IPIC was "slicing and dicing" their data, adding that there was no correlation in dose studies with efficacy, casting fundamental doubt on whether it works at all. Said that it may have some benefit as a nutritional supplement since it contains chemicals the brain uses to build cell membrane.... In a few words, relax, no competition here!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next